Non-interventional Study of Seroprevalence of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) and the Progression of Disease in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

ClinicalTrials.gov ID: NCT06311708

Public ClinicalTrials.gov record NCT06311708. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced May 19, 2026, 9:19 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Seroprevalence Study of Pre-existing Antibodies Against Adenovirus-associated Virus Vector (AAV9) in Patients With Plakophilin 2 (PKP2)-Associated Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC)

Study identification

NCT ID: NCT06311708
Recruitment status: Recruiting
Study type: Observational
Phase: Not listed
Lead sponsor: Tenaya Therapeutics; Industry
Enrollment: 200 participants

Conditions and interventions

Conditions

Arrhythmogenic Right Ventricular Cardiomyopathy

Interventions

Not listed

Eligibility (public fields only)

Age range: 14 Years to 65 Years
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jan 30, 2023
Primary completion: Mar 28, 2030
Completion: Jul 10, 2030
Last update posted: Oct 31, 2024

2023 – 2030

United States locations

U.S. sites: 8
U.S. states: 8
U.S. cities: 8

Facility	City	State	ZIP	Site status
University of California San Francisco	San Francisco	California	94143	Recruiting
University of Colorado, Denver	Aurora	Colorado	80045	Recruiting
John Hopkins University School of Medicine	Baltimore	Maryland	21287	Recruiting
Brigham and Women's Hospital	Boston	Massachusetts	02115	Recruiting
Mayo Clinic	Rochester	Minnesota	55905	Recruiting
New York University	New York	New York	10016	Recruiting
Cleveland Clinic	Cleveland	Ohio	44195	Recruiting
Medical University of South Carolina	Charleston	South Carolina	29425	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 13 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT06311708, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Oct 31, 2024 · Synced May 19, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06311708 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →